SOPHiA GENETICS (NasdaqGS:SOPH) Q3 2025 Earnings Call November 04, 2025 08:00 AM ET Speaker6Good morning. My name is Kelsey, and I'll be your conference operator today. At this time, I would like to welcome everyone to the SOPHiA GENETICS Q3 2025 earnings conference call. Kellen Sanger, SOPHiA GENETICS Head of Strategy & Investor Relations, you may begin.Speaker5Thank you, and good morning, everyone. Welcome to the SOPHiA GENETICS Q3 2025 earnings conference call. Joining me today to discuss the results are ...

Accessibility StatementSkip Navigation BOSTON and ROLLE, Switzerland, Nov. 4, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today reported financial results for the third quarter ended September 30, 2025. Third Quarter  2025 Financial Results 2025 Financial Outlook Driving strong business growth in the U.S. market Revenue was $19.5 million, up 23% year-over-year Gross margin was 66.3% on a reported basis and 73.1% on an adjusted basis, compared to 67 ...